The role of fibrosis in Duchenne muscular dystrophy
- PMID: 23620650
- PMCID: PMC3631802
The role of fibrosis in Duchenne muscular dystrophy
Abstract
Muscular dystrophies such as Duchenne muscular dystrophy (DMD) are usually approached as dysfunctions of the affected skeletal myofibres and their force transmission. Comparatively little attention has been given to the increase in connective tissue (fibrosis) which accompanies these muscular changes. Interestingly, an increase in endomysial tissue is apparent long before any muscular degeneration can be observed. Fibrosis is the result of a reactive or reparative process involving mechanical, humoral and cellular factors. Originating from vulnerable myofibres, muscle cell necrosis and inflammatory processes are present in DMD. Muscular recovery is limited due to the limited number and capacity of satellite cells. Hence, a proactive and multimodal approach is necessary in order to activate protective mechanisms and to hinder catabolic and tissue degrading pathways. Several avenues are discussed in terms of potential antifibrotic therapy approaches. These include pharmaceutical, nutritional, exercise-based and other mechanostimulatory modalities (such as massage or yoga-like stretching) with the intention of exerting an anti-inflammatory and antifibrotic effect on the affected muscular tissues. A preventive intervention at an early age is crucial, based on the early and seemingly non-reversible nature of the fibrotic tissue changes. Since consistent assessment is essential, different measurement technologies are discussed.
Keywords: Duchenne muscular dystrophy; TGF-β1; antifibrotic therapy; endo- and perimysium; extracellular matrix; fibrosis; myostatin.
Figures
References
-
- Duchenne GB. Recherches sur la paralysie musculaire pseudo- hypertrophique ou paralysie myosclerosique. Arch Gen Ned. 1868;11:5–552. 5,178,305,421,552.
-
- Emery AEH, Emery MLH. Duchenne muscular dystrophy or Meryon's disease. 2nd ed. Oxford: Oxford University Press; 2011.
-
- Bell CD, Conen PE, et al. Histopathological changes in Duchenne muscular dystrophy. J Neurol Sci. 1968;7:529–544. - PubMed
-
- Duance VC, Stephens HR, Dunn M, et al. A role for collagen in the pathogenesis of muscular dystrophy? Nature. 1980;284:470–471. - PubMed
-
- Desguerre I, Mayer M, Leturcq F, et al. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol. 2009;68:762–773. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources